Advertisement

Consider SGLT2 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease

Approximately two-thirds of deaths related to type 2 diabetes are attributable to cardiovascular disease (CVD). Interventions to reduce cardiovascular risks in patients...

Personalized Care for Depression Improves Outcomes

Major depressive disorder is the greatest cause of workplace disability, and depressive disorders are the world’s second greatest public health issue. During a presentation...

Managed Care Considerations for the Management of Rheumatoid Arthritis

Rheumatoid arthritis (RA) affects about 1.3 million Americans and, in 2010, was associated with $39 billion in medical costs. Choosing a treatment option can...

Inclusion of Patients in Treatment Decision-Making Improves Adherence in Multiple Sclerosis

Multiple sclerosis (MS) is a lifelong, complex, heterogenous, neurodegenerative disease with more than 20 disease-modifying therapeutic treatment options. During a presentation at NAMCP 2020...

A Closer Look at Targeted Therapies for Advanced Breast Cancer

Individualized treatment for breast cancer has improved clinical and economic outcomes. During a presentation at NAMCP 2020 Virtual Spring Managed Care Forum, Hatem Soliman,...
Advertisement